Daily Newsletter

28 September 2023

Daily Newsletter

28 September 2023

Nexus Health Systems opens new children’s hospital in Dallas

The facility looks after children after they've been treated at other hospitals and psychiatric facilities.

September 28 2023

US-based inpatient speciality hospital network Nexus Health Systems has launched the Nexus Children’s Hospital in Dallas, Texas, US.

The new Nexus Children’s Hospital - Dallas is a post-acute care facility that treats children and young adults who have serious injuries or illnesses such as brain or spinal cord injuries and autism, among others.

This facility takes care of children after they have been treated at other hospitals and psychiatric facilities, helping them get better and go home faster.

Spanning over 80,000ft², the Dallas hospital comprises 60 private rooms, along with advanced rehabilitation and therapy gyms, indoor and outdoor play areas, and a soothing sensory room for children with severe developmental disorders.

Nexus Children's Hospital has been assisting children for about 25 years with special programmes.

The hospital’s Harbor Program is intended for children who need long-term care after an injury or illness, while its New Directions Program helps children with behaviour problems, medical issues, or communication challenges.

Additionally, its RISE Program assists children with brain or spinal cord injuries.

Nexus Children's Hospital - Dallas CEO Bill Elsesser said: "Our interdisciplinary team of physical medicine and rehabilitation physicians, paediatricians, rehabilitation therapists, speech-language pathologists, respiratory therapists, psychiatrist, mental health therapists and counsellors, dieticians, nursing staff and administration has designed and prepared this hospital to be the best place for a child to come to who needs a bridge between hospital and home.”

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Primarily due to COVID-19, the healthcare sector has witnessed an acceleration in digital transformation, which has improved efficiencies and enhanced patient outcomes. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close